article · Bristol Research (University of Bristol) · 2005
Colorectal cancer prognosis: is it all mutation, mutation, mutation?
Hassan, AB, Paraskeva, C
Cited by 0Abstract and details only
Abstract
For the 500,000 new cases of colorectal cancer in the world each year, identification of patients with a worse prognosis and those who are more likely to respond to treatment is a challenge. There is an increasing body of evidence correlating genetic mutations with outcome in tumours derived from human colorectal cancer cohorts. K-ras, but not p53 or APC, mutations appear to be associated with poorer overall survival in colorectal cancer patients.
Cite this paper
Hassan, A., & Paraskeva, C. (2005). Colorectal cancer prognosis: is it all mutation, mutation, mutation? Bristol Research (University of Bristol).
Hassan, AB, and C Paraskeva. “Colorectal cancer prognosis: is it all mutation, mutation, mutation?” Bristol Research (University of Bristol), 2005.
Hassan, AB, and C Paraskeva. 2005. “Colorectal cancer prognosis: is it all mutation, mutation, mutation?” Bristol Research (University of Bristol).
Hassan, A. and Paraskeva, C. (2005) ‘Colorectal cancer prognosis: is it all mutation, mutation, mutation?’, Bristol Research (University of Bristol).
@article{hassan2005colorectal,
title = {{Colorectal cancer prognosis: is it all mutation, mutation, mutation?}},
author = {Hassan, AB and Paraskeva, C},
journal = {Bristol Research (University of Bristol)},
year = {2005}
}Made from the index record. Check names, capitalisation and page numbers against the paper. Need another style? AI for Research has over 10,000.